glp-1 shortage guidance Updated from the PCDS and ABCD: Managing the national RA MCT2D | 2023 Updates to

Compounding is regulated under FD&C Act Section 503A

What symptoms would require me to contact you or seek urgent medical attention

Safety Considerations and Who Should Start GLP-1 Therapy GLP-1 agonists are contraindicated in personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2

Alcohol use disorder is a brain disorder characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences

Alcohol interacts with GLP-1 medications in several ways

Retatrutide is unique in also targeting glucagon receptors, hence Lillys nickname for it: triple G. In short, retatrutide is a triple-receptor agonist , hitting GLP-1, GIP, and glucagon receptors all at once